share_log

阿里健康:持續關連交易— (1)重續現有持續關連交易協議及 (2)訂立2025年至2027年股權結算框架協議

ALI HEALTH: CONTINUING CONNECTED TRANSACTIONS -- (1) RENEWAL OF EXISTING CCT AGREEMENTS AND (2) ENTERING INTO OF 2025-2027 EBA SETTLEMENT FRAMEWORK AGREEMENT

香港交易所 ·  Mar 28 09:57
Summary by Moomoo AI
阿里健康信息技術有限公司宣布,將於2024年3月31日續簽現有持續關連交易協議,並訂立2025年至2027年股權結算框架協議。該續簽協議將從2024年4月1日開始,至2027年3月31日結束,而部分協議將於2025年3月31日結束。同時,公司與阿里巴巴控股訂立新的股權結算框架協議,有效期同樣為2024年4月1日至2027年3月31日。此舉旨在為集團實體間調動的僱員保留股權獎勵,並合理分配股權獎勵成本。阿里巴巴控股為阿里健康的最終控股股東,而淘寶控股、Ali JK、Perfect Advance及阿里巴巴投資為其股東。所有交易均遵守上市規則第14A章的申報、年度審閱及公告規定,但獲豁免獨立股東批准。董事會已批准相關協議,並將繼續監察其施行情況。
阿里健康信息技術有限公司宣布,將於2024年3月31日續簽現有持續關連交易協議,並訂立2025年至2027年股權結算框架協議。該續簽協議將從2024年4月1日開始,至2027年3月31日結束,而部分協議將於2025年3月31日結束。同時,公司與阿里巴巴控股訂立新的股權結算框架協議,有效期同樣為2024年4月1日至2027年3月31日。此舉旨在為集團實體間調動的僱員保留股權獎勵,並合理分配股權獎勵成本。阿里巴巴控股為阿里健康的最終控股股東,而淘寶控股、Ali JK、Perfect Advance及阿里巴巴投資為其股東。所有交易均遵守上市規則第14A章的申報、年度審閱及公告規定,但獲豁免獨立股東批准。董事會已批准相關協議,並將繼續監察其施行情況。
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. ANNOUNCED THAT IT WILL BE EXTENDING THE EXISTING CONTINUING CONNECTED TRANSACTION AGREEMENT ON MARCH 31, 2024 AND ESTABLISHING AN EQUITY SETTLEMENT FRAMEWORK AGREEMENT FOR 2025 TO 2027. The renewal agreement will run from April 1, 2024 to March 31, 2027, and part of the agreement will end on March 31, 2025. At the same time, the company entered into a new equity settlement framework agreement with Alibaba Holdings, which will be valid from 1 April 2024 to 31 March 2027. This move aims to preserve equity awards for employees moving between the Group's entities and to allocate equity award costs appropriately. Alibaba Holdings is the ultimate holding shareholder of Ali Health, while Taobao Holdings, Ali JK, Perfect Advance and Alibaba are its investors. All transactions are subject to the reporting, annual review and announcement requirements of Chapter 14A of the Listing Rules, but are exempt from approval by independent shareholders. The Board of Directors has approved the relevant agreement and will continue to monitor its implementation.
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. ANNOUNCED THAT IT WILL BE EXTENDING THE EXISTING CONTINUING CONNECTED TRANSACTION AGREEMENT ON MARCH 31, 2024 AND ESTABLISHING AN EQUITY SETTLEMENT FRAMEWORK AGREEMENT FOR 2025 TO 2027. The renewal agreement will run from April 1, 2024 to March 31, 2027, and part of the agreement will end on March 31, 2025. At the same time, the company entered into a new equity settlement framework agreement with Alibaba Holdings, which will be valid from 1 April 2024 to 31 March 2027. This move aims to preserve equity awards for employees moving between the Group's entities and to allocate equity award costs appropriately. Alibaba Holdings is the ultimate holding shareholder of Ali Health, while Taobao Holdings, Ali JK, Perfect Advance and Alibaba are its investors. All transactions are subject to the reporting, annual review and announcement requirements of Chapter 14A of the Listing Rules, but are exempt from approval by independent shareholders. The Board of Directors has approved the relevant agreement and will continue to monitor its implementation.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more